Overview
Parkinson's disease (PD) is one of the most common neurodegenerative diseases characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra compacta (SNc) and aggregation of Lewy bodies in neurons. Although aging, oxidative damage and neuroinflammation have been recognized to play crucial roles in the pathogenesis of PD, the precise etiology remains obscure. Emerging evidence suggests PD is a systemic metabolic disease, and metabolic abnormality correlates with functional alternations in PD
Eligibility
Inclusion Criteria:
Age ≥ 18 years Both males and females will be included Negative pregnancy test and
effective contraception. Diagnosed Parkinson's disease patient taking Levodopa
Exclusion Criteria:
Secondary causes of Parkinsonism Diabetic patients Patients taking anti-inflammatory drugs
Atypical parkinsonian syndromes Prior stereotaxic surgery for Parkinson's disease Pregnancy
and lactation Suffering from active malignancy Addiction to alcohol and/or drugs Known
allergy to the studied medications